Table 4. SVM classification with 10-fold cross validation to classify samples into normal, primary or metastasis using protein or miRNA expression profiles.

Protein complexes	miRNA
Arul data	GSE23022
Primary vs. Normal: 85%	Primary vs. Normal:77.5%
Primary vs. Metastasis: 100%
Normal vs. Metastasis: 100%
	NCI60 (Normal vs. Primary tumor)
Yu data	Prostate: 91%
Primary vs. Normal: 80%	Colon:100%
Primary vs. Metastasis: 83%	Kidney: 100%
Normal vs. Metastasis: 76%	Lung: 100%
	Breast 100%